These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11774209)

  • 1. [Association between dopamine transporter gene polymorphism and Parkinson's disease].
    Zhang L; Shao M; Xu Q; Dong X; Yang J; Li Y; Chen B
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Dec; 18(6):431-4. PubMed ID: 11774209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Association between genetic polymorphism of dopamine transporter gene and susceptibility to Parkinson's disease].
    Wang J; Liu Z; Chen B
    Zhonghua Yi Xue Za Zhi; 2000 May; 80(5):346-8. PubMed ID: 11798784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between dopamine transporter gene polymorphism and susceptibility to Parkinson's disease in Japan.
    Nishimura M; Kaji R; Ohta M; Mizuta I; Kuno S
    Mov Disord; 2002 Jul; 17(4):831-2. PubMed ID: 12210886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of a polymorphism in the dopamine-transporter gene with Parkinson's disease.
    Le Couteur DG; Leighton PW; McCann SJ; Pond Sm
    Mov Disord; 1997 Sep; 12(5):760-3. PubMed ID: 9380062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association study of dopamine transporter gene and schizophrenia in Korean population using multiple single nucleotide polymorphism markers.
    Jeong SH; Joo EJ; Ahn YM; Kim YS
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Sep; 28(6):975-83. PubMed ID: 15380858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case-control study of dopamine transporter-1, monoamine oxidase-B, and catechol-O-methyl transferase polymorphisms in Parkinson's disease.
    Goudreau JL; Maraganore DM; Farrer MJ; Lesnick TG; Singleton AB; Bower JH; Hardy JA; Rocca WA
    Mov Disord; 2002 Nov; 17(6):1305-11. PubMed ID: 12465073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The homozygote 10-copy genotype of variable number tandem repeat dopamine transporter gene may confer protection against Parkinson's disease for male, but not to female patients.
    Lin JJ; Yueh KC; Chang DC; Chang CY; Yeh YH; Lin SZ
    J Neurol Sci; 2003 May; 209(1-2):87-92. PubMed ID: 12686408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lack of association between VNTR polymorphism of DAT gene and schizophrenia].
    Hauser J; Kapelski P; Czerski PM; Godlewski S; Dmitrzak-Weglarz M; Twardowska K; Rybakowski JK
    Psychiatr Pol; 2002; 36(3):403-12. PubMed ID: 12149916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smoking status and the human dopamine transporter variable number of tandem repeats (VNTR) polymorphism: failure to replicate and finding that never-smokers may be different.
    Vandenbergh DJ; Bennett CJ; Grant MD; Strasser AA; O'Connor R; Stauffer RL; Vogler GP; Kozlowski LT
    Nicotine Tob Res; 2002 Aug; 4(3):333-40. PubMed ID: 12215242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of association between dopamine transporter gene polymorphisms and delusional disorder.
    Persico AM; Catalano M
    Am J Med Genet; 1998 Mar; 81(2):163-5. PubMed ID: 9613856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine transporter gene polymorphism and psychiatric symptoms seen in schizophrenic patients at their first episode.
    Inada T; Sugita T; Dobashi I; Inagaki A; Kitao Y; Matsuda G; Kato S; Takano T; Yagi G; Asai M
    Am J Med Genet; 1996 Jul; 67(4):406-8. PubMed ID: 8837710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of association between polymorphic microsatellites of the VMAT2 gene and Parkinson's disease in Japan.
    Kariya S; Hirano M; Takahashi N; Furiya Y; Ueno S
    J Neurol Sci; 2005 May; 232(1-2):91-4. PubMed ID: 15850588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allelic variation of serotonin transporter expression is associated with depression in Parkinson's disease.
    Mössner R; Henneberg A; Schmitt A; Syagailo YV; Grässle M; Hennig T; Simantov R; Gerlach M; Riederer P; Lesch KP
    Mol Psychiatry; 2001 May; 6(3):350-2. PubMed ID: 11326308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Association between cytochrome P-450 enzyme gene polymorphisms and Parkinson's disease].
    Wang J; Liu Z; Chen B
    Zhonghua Yi Xue Za Zhi; 2000 Aug; 80(8):585-7. PubMed ID: 11798822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of the dopamine transporter gene with Parkinson's disease in Korean patients.
    Kim JW; Kim DH; Kim SH; Cha JK
    J Korean Med Sci; 2000 Aug; 15(4):449-51. PubMed ID: 10983695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nine- or fewer repeat alleles in VNTR polymorphism of the dopamine transporter gene is a strong risk factor for prolonged methamphetamine psychosis.
    Ujike H; Harano M; Inada T; Yamada M; Komiyama T; Sekine Y; Sora I; Iyo M; Katsu T; Nomura A; Nakata K; Ozaki N
    Pharmacogenomics J; 2003; 3(4):242-7. PubMed ID: 12931138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allelic association of a dopamine transporter gene polymorphism with antisocial behaviour in heroin-dependent patients.
    Gerra G; Garofano L; Pellegrini C; Bosari S; Zaimovic A; Moi G; Avanzini P; Talarico E; Gardini F; Donnini C
    Addict Biol; 2005 Sep; 10(3):275-81. PubMed ID: 16109590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Case-control, family based and screening for DNA sequence variation in the dopamine transporter gene polymorphism DAT 1 in alcohol dependence].
    Grzywacz A; Samochowiec J
    Psychiatr Pol; 2008; 42(3):443-52. PubMed ID: 19899571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The alpha-synuclein gene microsatellite polymorphism and late-onset sporadic Parkinson's disease susceptibility].
    Zhao XP; Zheng HM; Xie HJ; Ding SJ; Ren DM
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Aug; 21(4):339-41. PubMed ID: 15300629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of tau gene polymorphism with Parkinson's disease.
    Zappia M; Annesi G; Nicoletti G; Serra P; Arabia G; Pugliese P; Messina D; Caracciolo M; Romeo N; Annesi F; Pasqua AA; Spadafora P; Civitelli D; Romeo N; Epifanio A; Morgante L; Quattrone A
    Neurol Sci; 2003 Oct; 24(3):223-4. PubMed ID: 14600827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.